Table 1.
Clinical features, surgery, and post-operative outcome (n = 39).
| Parameter | |
|---|---|
| Age (years), median (range) | 65 (45–81) |
| Sex, n | |
| Male | 21 |
| Female | 18 |
| Nephrectomy, n | |
| Left | 23 |
| Right | 16 |
| Stage RCC [12], n | |
| I | 2 |
| II | 14 |
| III | 20 |
| IV | 3 |
| Timing of RCC-PM, n | |
| Synchronous | 3 |
| Metachronous | 36 |
| Disease free interval (months), median (range) | 84 (7–291) |
| Number of RCC-PM, n | |
| Single | 18 |
| Multiple | 21 |
| Other sites of metastases, n | |
| No | 32 |
| Abdominal | 3 local relapse, 1 contralateral kidney, 1 adrenal |
| Extra-abdominal | 1 lung, 1 thyroid |
| Pancreatic metastases size (cm), median (range) | 2.5 (0.7–7.5) |
| Type of pancreatic surgery, n | |
| Distal pancreatectomy | 13 |
| Total pancreatectomy | 12 |
| Pancreatico-duodenectomy | 8 (1 associated enucleation) |
| Limited resections | 3 spleen-preserving DP, 1 DPPHR, 2 CP (1 associated enucleation) |
| Associated surgery, n | |
| Splenectomy | 22 |
| Multi-visceral resections | 12 |
| Operation time (min), median (range) | 350 (150–720) |
| Intra-operative blood loss (mL), median (range) | 400 (100–1300) |
| Post-operative morbidity, n | |
| Post-operative pancreatic fistula | 9 (5 biochemical leak, 4 post-operative pancreatic fistula grade B) |
| Post-pancreatectomy hemorrhage | 2 |
| Delayed gastric emptying | 1 |
| Other cause | 9 |
| Post-operative mortality, n | 1 |
| Reoperation rate, n | 1 |
| Hospital stay (days), median (range) | 12 (6–133) |
CP–central pancreatectomy, DP–distal pancreatectomy, DPPHR–duodenum-preserving pancreatic head resection, n.a.–not available, RCC renal cell carcinoma, RCC-PM–pancreatic metastasis from renal cell carcinoma.